◆ 会议时间:2021年6月9-17日
◆ 会议地点:虚拟会议
◆ 会议简介:
2021年第26届欧洲血液学大会/年会(26th EHA Congress)-虚拟会议将于2021年6月9-17日举行,会议由欧洲血液学会(EHA)主办。欧洲血液年会(EHA年会)是全球血液学领域规模最大的国际会议之一,于每年的6月在欧洲一个主要城市举行。EHA大会主题涵盖了血液学研究的各个面,每年都有来自全球100多个国家的10000余名专业人士与会,一起分享探讨有关血液学的创新理念及最新的科学和临床研究成果。领域国际医学会议网。EHA大会的目标是提高与会者对血液病诊断和治疗的循证医学知识;了解血液学及其亚专科的最新创新技术、诊断工具和风险评估策略;与众多国际代表——医学专业人员、各国血液学会、患者团体、医疗行业和媒体——沟通、协作和联络。会议数字(EHA2019与会人数:12614人,其中中国与会者:546人)
欧洲血液学协会(EHA)成立于1992年,是致力于促进血液学临床实践、研究和教育的非营利性组织,是国际上最大的血液学知识独立提供商之一,目前在全球100多个国家拥有超过4500名成员,是欧洲最大的血液学组织。——未经本站许可,禁止复制转载摘录镜像本站任何内容-领域国际医学会议网。
EHA2021 Virtual
EHA continues to dedicate its efforts to guiding hematologists in both clinical and research settings.
Although face-to-face interactions are an important aspect of any congress, the current pandemic severely limits the possibilities. A core objective of EHA is to provide a platform for networking and connecting hematologists and EHA2021 will be no different. We will strive to maximize opportunities to promote the social side of our congress for our participants.
The EHA2021 Virtual Congress will be a key moment to consolidate the knowledge and experience gained worldwide and bring together hematologists in a virtual environment.
Hosting a virtual congress brings challenges and at the same time opens new possibilities. You can expect an interactive program dedicated to clinical research and practice, basic and translational research, as well as the important collaborations with stakeholders beyond hematology.
More details and information will be shared here soon.
Save the dates: the EHA2021 Virtual Congress will take place on June 9–17!
EHA2021: Stay tuned to immerse yourself once again in the latest news in hematology and its subspecialties:
- Cutting-edge evidence-based approaches to diagnosis and treatment
- Highly anticipated clinical and translational research data
- Newest developments in innovative techniques, diagnostic tools, and risk-assessment strategies
EHA2021 knows no bounds and is intended for medical professionals, national hematology societies, patient groups, medical industry, and media worldwide. |
EHA's dedication to excellence in patient care, research, and education in hematology is realized in bringing together professionals from all parts of the world through scientific and educational meetings the whole year through.
The Annual Congress of EHA is a flagship meeting held in a major European city every June—a significant meeting place for hematologists from every area of specialization. Our annual congresses encompass the entire spectrum of hematological studies, where you, together with 11,000 other participants who share your passion for this field, can learn about the latest findings and innovations.
Deadlines and important dates-重要日期
All deadlines, except if mentioned differently, end at 23:59 CET/CEST.
Date |
Deadline |
2020 December 15 |
Updates on scientific program available |
2021 March 1, 23:59 (CET) |
Deadline for abstract submission & participation grant application |
2021 March (TBC) |
Open registration |
2021 April 30; 23:59 (CEST) |
Deadline for early registration fee & cancellation with refund minus admin fee |
2021 May 7 |
Open Late-breaking abstract submission |
2021 May 12 |
Deadline for Late Breaking Abstract submission |
2021 May 12, 16:00 (CEST) |
Accepted abstracts available online |
2021 May 31; 23:59 (CEST) |
Deadline for regular registration fee & cancellation with 50% refund |
2021 June 1, 16:00 (CEST) |
Accepted Late Breaking Abstracts available online |
2021 (as of) June 1 |
Late registration fee start & cancellation without refund |
2021 June 9-17 |
EHA2021 Virtual Congress |
2021 August 15 |
EHA2021 Virtual Congress platform closes |
摘要提交-Abstract submission
Abstract procedure
The official abstract submission will open on January 1, 2021 and will close on March 1, 2021 (23:59 CET)/提交截止.
点此提交摘要>>>Submit Abstract>>>
Please note that the submission of an abstract constitutes a formal commitment by the presenting author to present the abstract (if accepted) orally or as a poster in the session and the time assigned by the Scientific Program Committee (SPC). We, therefore, recommend that submitter of an abstract registers for the Congress simultaneously with the abstract submission.
The abstracts submitted via the regular submission process will be reviewed and allocated by the international panel of reviewers and the SPC. The authors will be informed about the allocation latest by April 23, 2021.
Late-breaking abstract submission
Late-breaking abstract procedure
The official late-breaking abstract submission will be open from May 7-12, 2021 (23:59 CEST).
The EHA late-breaking abstracts policy allows for the submission of abstracts containing clinical or non-clinical data which were unavailable at the time of the abstract submission deadline (March 1, 2021). For clinical trials, a preplanned analysis of the primary endpoint should have been scheduled after this date.
Please note that due to the late scheduling of the procedure the selected late-breaking abstracts will be made available in the online version of the Abstract Book (supplement of HemaSphere, the official EHA Journal), the EHA Library (previously known as EHA Learning Center,) the mobile app and via the program on the EHA website.
Abstract authors will be informed about the results of the review by May 26, 2021.
EHA2021-虚拟会议-注册费-Registration fees
Please find below the deadlines and fees for registering to the EHA2021 Virtual Congress:
EHA Congress 2021
Registration fees |
Early Fee |
Regular Fee |
Late Fee |
Until April 30, 2021;
23:59 CEST |
Until May 31, 2021;
23:59 CEST |
Until registration close |
Non-Member (Junior & Regular) |
€ 149 |
€ 199 |
€ 249 |
EHA Member* |
€ 69 |
€ 119 |
€ 149 |
Junior EHA Member */** |
€ 59 |
€ 79 |
€ 99 |
YERM only |
€ 10 |
€ 10 |
€ 15 |
The registration fees include 21% Dutch VAT.
* EHA members who have paid their 2021 membership fee before May 24, 2021.
** Participants up to 36 years of age (born in 1984 or after).
未来的EHA年会:
27th Congress of EHA |
Date: June 9 - 12, 2022
EHA 2021-欧洲血液学年会-2021欧洲EHA血液年会-2021eha会议-欧洲血液年会-EHA血液学大会
◆ 参会对象:医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|